Highlights Kobayashi Pharmaceutical Co., Ltd.

Equities

4967

JP3301100008

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-31 am EDT			5-day change	1st Jan Change
5,429 ^JPY	+0.15%		-5.35%	-20.04%

May. 24	Japan companies hog the spotlight as hedge funds tout their top Asia picks	RE
Mar. 31	A second Kobayashi Pharma Japan factory inspected over deaths	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

A second Kobayashi Pharma Japan factory inspected over deaths	Mar. 31	RE
Final dividend	Dec. 27	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.	Nov. 07	CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million.	Nov. 07	CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC.	23-10-06	CI
Ex-dividend day for interim dividend	23-06-28	FA
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Ex-dividend day for final dividend	22-12-28	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.	22-11-01	CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million.	22-11-01	CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.	22-11-01	CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	22-10-31	CI
Ex-dividend day for interim dividend	22-06-28	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.	22-02-14	CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on October 28, 2021, has expired with 883,300 shares, representing 1.13% for ¥7,999.54 million.	22-02-09	CI
Ex-dividend day for final dividend	21-12-28	FA
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,000,000 shares, representing 1.28% for ?8,000 million.	21-10-28	CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	21-10-27	CI
Ex-dividend day for interim dividend	21-06-28	FA
Ex-dividend day for final dividend	20-12-28	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kobayashi Pharmaceutical Co., Ltd.

Equities

4967

JP3301100008

Highlights

Filters